ECS BOTANICS HOLDINGS LTD — Board/Management Information 2021

Sep 19, 2021

ASX ANNOUNCEMENT ECS Botanics Holdings Ltd (ASX:ECS)

20 September 2021

==> picture [90 x 87] intentionally omitted <==

Industry leading advisory board established

• Advisory board established to leverage industry leading expertise and unlock new opportunities across ECS’ medicinal cannabis business

• Six appointments made, all members are industry leaders with extensive experience in manufacturing, agriculture, cultivation, pharmaceuticals and business growth

• Advisory board members include:

  • ➢ David Bellamy – Founder of Bellamy’s Organic with a track record of achieving business success across diverse industries including agriculture and start-ups.

  • ➢ Dr James Connell – President of Society of Cannabis Clinicians Australian Chapter, chief medical officer, and co-founder of Heyday Clinics.

  • ➢ Tad Hussey – Owner of US company KIS Organics and host of the “Cannabis Cultivation and Science” Podcasts helping to bridge the gap between agriculture, horticulture, and the cannabis industry.

  • ➢ Vee Revithi - Ex-Medicine Head of the GMDP Inspectorate of the Greek Medicines’ Authority with 36 years’ experience in EU regulatory affairs.

  • ➢ Graeme Sait – World renowned author and speaker on the relationship between soil, plant and human health and link between humus and carbon sequestration, as well as CEO and co-founder of Nutri-Tech Solutions.

  • ➢ Trevor Schoerie – Managing Director of internationally recognised multi-disciplinary pharmaceutical consultancy PharmOut.

ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”) is pleased to advise that it has established an advisory board to assist the Company with its ongoing growth trajectory.

As part of the initiative, ECS has appointed six industry leaders, all with extensive expertise across scaling businesses, organic and regenerative farming, cannabis cultivation and pharmaceutical compliance and manufacturing.

ECS will leverage the experience of each member to develop and refine business processes and to expedite strong growth across its medicinal cannabis business. Profiles of each advisory board member can be found via the following link: https://www.ecs-botanics.com/ecs-botanics-advisoryboard/

Managing Director, Alex Keach said: “We are incredibly grateful to have attracted a world class advisory board who share our values and vision. Each member is exceptional in their chosen field and has a track record of innovation and success. The entire ECS team benefit from direct access to the Advisory Board. We strongly believe that through bringing together diversity of thought and great minds, amazing outcomes will be achieved. The advisory board will allow ECS to remain at the leading edge and maintain a strong growth trajectory whilst retaining discipline and governance.”

==> picture [596 x 65] intentionally omitted <==

-ENDS-

==> picture [90 x 87] intentionally omitted <==

About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd is a vertically integrated medicinal cannabis and industrial hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufactures to EU GMP standards and also has the necessary licences to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licences to grow, supply and manufacture. ECS’ core focus is scale and lowcost production, without compromising quality.

For further information, please contact: Alexander Keach, Managing Director info@ecsbotanics.com.au

Authorised on behalf of ECS by Alex Keach, Managing Director

==> picture [596 x 63] intentionally omitted <==